Ustekinumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Ustekinumab is used to treat psoriatic arthritis, ulcerative colitis, crohn disease and psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3.4 billion on Ustekinumab across 133,000 claims for 25,000 beneficiaries.
Ustekinumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $29792.79 to $29874.45 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$29792.79 – $29874.45
per ML
7d Activity
avg -0.2% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing USTEKINUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STELARA 45 MG/0.5 ML SYRINGE | $29874.4480 per ML | — |
STELARA 90 MG/ML SYRINGE | $29792.7867 per ML | -0.17% |
Frequently Asked Questions
What is Ustekinumab used to treat?
Ustekinumab is used to treat psoriatic arthritis, ulcerative colitis, crohn disease and psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Ustekinumab?
In 2024, Medicare Part D spent $3.4 billion on Ustekinumab across 133,000 claims for 25,000 beneficiaries.
How many Ustekinumab products are on the market?
The Ustekinumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Ustekinumab?
NADAC reference prices for Ustekinumab range from $29792.7867 to $29874.4480 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Ustekinumab?
1 manufacturer lists Ustekinumab in NADAC. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (2).
How has the price of Ustekinumab changed recently?
Over the past 7 days, 0 Ustekinumab NDCs rose and 2 fell, with a market-wide average change of -0.2%.